arrow_back Back to App

September 2024: National Ovarian Cancer Awareness Month in the US

This House Resolution supports designating September 2024 as National Ovarian Cancer Awareness Month. The aim is to boost public knowledge about the symptoms and risks of ovarian cancer, potentially leading to earlier detection and improved treatment outcomes, especially for underserved communities.
Key points
Increased awareness of ovarian cancer can lead to quicker diagnosis, which is vital for survival rates.
There is no reliable early detection test for ovarian cancer, making symptoms often confused with other conditions.
The resolution highlights the need for better access to care and genetic testing, particularly for high-risk groups and minorities.
Support for ovarian cancer research and education is crucial for improving patient outcomes.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_1508
Sponsor: Rep. DeLauro, Rosa L. [D-CT-3]
Process start date: 2024-09-25
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Supporting the designation of September 2024 as "National Ovarian Cancer Awareness Month".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_1508.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-09-25.

What are the main provisions?

Key points include:

  • Increased awareness of ovarian cancer can lead to quicker diagnosis, which is vital for survival rates.
  • There is no reliable early detection test for ovarian cancer, making symptoms often confused with other conditions.
  • The resolution highlights the need for better access to care and genetic testing, particularly for high-risk groups and minorities.
  • Support for ovarian cancer research and education is crucial for improving patient outcomes.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. DeLauro, Rosa L. [D-CT-3].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Oversight and Accountability.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health